The Brain Tumor Panel 2 is an advanced molecular testing panel designed to detect key genetic alterations associated with brain tumors. Metropolis Healthcare uses high-precision technologies to analyze tumor-related genes that help guide diagnosis, prognosis, and treatment planning. This test supports clinicians in identifying actionable mutations and tailoring targeted therapy decisions. It is especially useful when conventional diagnostics require deeper genomic insight.
Price:
Rs. 26,500.00
Sample Type: Slide , Tissue
Fasting Not Required
Notes:G0082
Frequently Asked Questions (FAQ's):
What does this test include at Metropolis Healthcare?
It includes molecular analysis of multiple genes associated with primary and secondary brain tumors.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced sequencing and molecular techniques to detect genetic mutations with high sensitivity.
Who should undergo this test at Metropolis Healthcare?
Patients with confirmed or suspected brain tumors who require genetic profiling for diagnosis or treatment planning.
What sample is needed for this test at Metropolis Healthcare?
Tumor tissue or relevant clinical samples as advised by the treating physician.
How does this panel help in treatment decisions at Metropolis Healthcare?
It identifies mutations that guide targeted therapy, chemotherapy response, and prognosis.
Is any preparation required before giving the sample at Metropolis Healthcare?
No special preparation is needed; sample collection is performed as per clinical requirement.
How long does the testing process take at Metropolis Healthcare?
Turnaround time varies depending on the complexity but typically ranges from several days to a few weeks.
When can I expect the reports from Metropolis Healthcare?
Reports are provided as per the standard molecular diagnostics timeline, with detailed interpretation for clinicians.